Greater Pacific Northwest Retriever Trial Club Inc
ICO
930906826
Web
Sign in to see organisation website
Address
Keizer
From Social media
News about from their social media (Facebook and X).
Data about organisation
Keizer
Organisations from Greater Pacific Northwest Retriever Trial Club Inc
YPO is the global leadership community of more than 35,000 chief executives in 142 countries.
Oregon Right to Life advocates for the most vulnerable human beings whose right to life is denied or abridged under current law.
FOF Adoption Center hours: MONDAY-SUNDAY 11:00 AM-6:00 PM.
4. Keizer Volunteer Firefighters Association Inc
This is the Official Facebook Page of Keizer Fire District.
Get Involved- Inform, Interact, Influence.
Interesting nearby
Interesting organisations close by to residence of Greater Pacific Northwest Retriever Trial Club Inc
Youth Boys Lacrosse League.
The fun of snowmobiling in the beautiful state of Oregon.
Join us and make a difference for the future!
Eduo is where compassion meets clarity.
William
Eduo connects you to causes that actually matter to you.
Janet
Eduo.org makes finding trustworthy nonprofits refreshingly simple.
Brian
A brilliant resource for anyone who wants to do good more effectively.
Joanna
Great for discovering hidden-gem organizations near me.
Barbara
The idea behind Eduo is genius — let the community build and improve profiles of nonprofit organizations worldwide. It creates trust and motivates engagement.
Paul
Sign Up
Please fill in your information. Everything is free, we might contact you with updates (but cancel any time!)
Sign in with GoogleOr
Good News
Peter
2025-10-25
Exciting times ahead for Clarington and Durham as the Darlington SMR Project takes shape! 🌍✨ With advancements in nuclear energy, we're on the brink of a sustainable future. Let's support progress and innovation for our communities! #PositiveNews #Sustainability #NuclearEnergy
'World is at our doorstep': Clarington, Durham poised to benefit from Darlington SMR Project
Yahoo
Like Comment
Cathy
2025-10-25
Exciting news from ITM! 🚀 Their Phase 3 COMPETE trial shows promising results for n.c.a. 177Lu-edotreotide, offering hope for patients with GEP-NETs. Together, we're witnessing advancements in healthcare that make a real difference! 💪💙 #CancerResearch #Hope #PositiveNews
ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025
StreetInsider.com
Like Comment